Lesson plan
Pyronaridine
Pyronaridine is an antimalarial drug. It was first made in 1970 and has been in clinical use in China since the 1980s. In a small (n=88) malaria study in Cameroon, pyronaridine had a 100% cure rate, compared with 60% for chloroquine. It is one of the components of the artemisinin combination therapy pyronaridine/artesunate (Pyramax). It has also been studied as a potential anticancer drug, and treatment for Ebola. The combination of pyronaridine and artesunate has been evaluated to have a synergistic effect of stronger antiviral effect and less toxicity. The combination of pyronaridine and artesunate is being studied as a possible treatment for moderate to severe SARS-COV-2.
Article summary
Pyronaridine is an antimalarial drug. It was first made in 1970 and has been in clinical use in China since the 1980s. In a small (n=88) malaria study in Cameroon, pyronaridine had a 100% cure rate, compared with 60% for chloroquine. It is one of the components of the artemisinin combination therapy pyronaridine/artesunate (Pyramax). It has also been studied as a potential anticancer drug, and treatment for Ebola. The combination of pyronaridine and artesunate has been evaluated to have a synergistic effect of stronger antiviral effect and less toxicity. The combination of pyronaridine and artesunate is being studied as a possible treatment for moderate to severe SARS-COV-2.
Key claims
No claims recorded.
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.